Tecnobar Competitors

Everforth Apex Systems, part of the Everforth ™ Network, is a leading global technology services company specializing in customizable industry-specific solutions that turns digital vision into real-world results. We provide end-to-end services across strategy, transformation, and managed services, with expertise in application development, data, enterprise platforms, cloud and infrastructure, and cybersecurity. Our alliances with leading technology providers enable us to bring cutting-edge capabilities to clients across more than 70 markets in North America, Europe, and India. 📈 Everforth Apex is a part of the commercial segment of Everforth™ (NYSE: EFOR) Everforth Family of Brands: Everforth™ is a global technology and digital engineering company helping commercial enterprises and government agencies Adapt and Thrive™. We combine trusted expertise, AI-enabled solutions, and adaptive delivery to drive measurable outcomes at scale. 🔗 Everforth.com

At Precor, our mission is to deliver precision quality products with steadfast reliability that are inspired by exercisers and built to perform for the world’s best fitness facilities. Headquartered in the Greater Seattle area of Washington State in the United States, Precor has been a pioneer in delivering fitness experiences for commercial customers and exercisers for more than 40 years. Precor serves more than 100 countries worldwide, with offices in the Americas, EMEA and APAC, with U.S. based manufacturing. Precor products and services span across all major categories including cardio, strength, functional fitness, group training, and connected solutions. In 2020, Precor reached the milestone of recording one billion workouts with its connected fitness offering. Precor segments include commercial clubs/facilities and the verticals of hospitality, residential, corporate, and education. For more information, visit www.Precor.com.

Zambon is a chemical-pharmaceutical company founded on the history and values of an Italian family and committed to innovate cure and care to make patients' lives better. Present in Europe, America and Asia with over 2,700 employees and manufacturing units in Italy, Switzerland, France, China and Brazil, in 2024 the Group revenues amounted to 885 million euros. Zambon SpA, the pharma subsidiary of the group with its 23 branchess and products commercialized in 87 countries, has taken a new role in the industry. In addition to pain and diseases of the respiratory system and urological system, Zambon is establishing a global pipeline and introducing important treatments for serious diseases such as Parkinson’s Disease, Cystic Fibrosis, BOS and NCFB. In recent years the Group established ZBiotech, a specialized biotech company that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules. Zambon also produces high quality products thanks to the management of the whole production chain which involves Zach-Zambon Chemicals, a privileged partner for API, custom synthesis and generic products. Zambon complements the offering of medicines with modern health solutions. Through Zcube-Zambon Research Venture it actively scouts and supports the growth of innovative projects and startups. The Zambon group also includes ItaliAssistenza, a Home Care Company involved in the design and delivery of patient support programs (PSP) and home care services. Zambon was established in 1906 in Vicenza and is headquartered in Milan within OpenZone, the scientific campus where knowledge is shared between partners in the field of Healthcare, founded with the aim to transform research into enterprise.